The FDA has authorized marketing of Cerebra Medical Ltd’s Cerebra Sleep System, a type II and III home sleep testing device with a patented sleep depth algorithm.
Read More
This full-body MRI approval expands the Inspire use labeling that previously allowed only head, neck, and extremity MRI scans.
Read More
What do the recent advances in type II home sleep testing mean for sleep medicine?
Read More
Apnimed’s AD109 has the potential to be the first oral pharmacologic that treats OSA airway obstruction at night.
Read More
The American Heart Association advisory notes that both too much and too little sleep are associated with heart disease.
Read More